-
R.
Gopal,
L.
Monin,
Samantha
Slight,
Uzodinma
Uche,
E.
Blanchard,
Beth
Junecko,
R.
Ramos-Payán,
Christina
Stallings,
T.
Reinhart,
J.
Kolls,
D.
Kaushal,
U.
Nagarajan,
J.
Rangel-Moreno,
S.
Khader
(2014)
Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
PLoS Pathogens, 10
-
S.
Baldwin,
S.
Bertholet,
V.
Reese,
Lance
Ching,
S.
Reed,
R.
Coler
(2012)
The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
The Journal of Immunology, 188
-
J.
Bayry,
E.
Tchilian,
M.
Davies,
Emily
Forbes,
S.
Draper,
S.
Kaveri,
A.
Hill,
M.
Kazatchkine,
P.
Beverley,
D.
Flower,
D.
Tough
(2008)
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination
Proceedings of the National Academy of Sciences, 105
-
(2010)
Protection against M. tuberculosis HN878 with ID93/GLA-SE February 2016 Volume 23 Number 2 cvi.asm.org 145 Clinical and Vaccine
-
Simone
Ribeiro,
L.
Gomes,
E.
Amaral,
Marcelle
Andrade,
F.
Almeida,
Andreza
Rezende,
V.
Lanes,
E.
Carvalho,
P.
Suffys,
I.
Mokrousov,
E.
Lasunskaia
(2014)
Mycobacterium tuberculosis Strains of the Modern Sublineage of the Beijing Family Are More Likely To Display Increased Virulence than Strains of the Ancient Sublineage
Journal of Clinical Microbiology, 52
-
Ryan
Anderson,
C.
Fox,
Timothy
Dutill,
N.
Shaverdian,
Tara
Evers,
G.
Poshusta,
J.
Chesko,
R.
Coler,
M.
Friede,
S.
Reed,
T.
Vedvick
(2010)
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations.
Colloids and surfaces. B, Biointerfaces, 75 1
-
D.
Jevtović,
D.
Salemović,
J.
Ranin,
B.
Brmbolić,
O.
Djurković-Djaković
(2009)
The prognosis of pediatric AIDS in serbia.
Current HIV research, 7 3
-
M.
Arias,
G.
Roey,
J.
Tregoning,
Magdalini
Moutaftsi,
R.
Coler,
H.
Windish,
S.
Reed,
D.
Carter,
R.
Shattock
(2012)
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
PLoS ONE, 7
-
P.
Andersen,
T.
Doherty
(2005)
The success and failure of BCG — implications for a novel tuberculosis vaccine
Nature Reviews Microbiology, 3
-
Deepak
Almeida,
C.
Rodrigues,
T.
Ashavaid,
A.
Lalvani,
Z.
Udwadia,
A.
Mehta
(2005)
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 40 6
-
T.
Kubica,
S.
Rüsch-Gerdes,
S.
Niemann
(2004)
The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 8 9
-
C.
Clegg,
R.
Roque,
Lucy
Perrone,
J.
Rininger,
R.
Bowen,
S.
Reed
(2014)
GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
PLoS ONE, 9
-
Ronggai
Sun,
Y.
Skeiky,
A.
Izzo,
V.
Dheenadhayalan,
Zakaria
Imam,
Erica
Penn,
Katherine
Stagliano,
S.
Haddock,
S.
Mueller,
J.
Fulkerson,
C.
Scanga,
A.
Grover,
S.
Derrick,
S.
Morris,
D.
Hone,
M.
Horwitz,
S.
Kaufmann,
J.
Sadoff
(2009)
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Vaccine, 27 33
-
S.
Lambert,
S.
Aslam,
E.
Stillman,
Mia
MacPhail,
Christine
Nelson,
Bodrey
Ro,
Rosemary
Sweetwood,
Yu
Lei,
Jennifer
Woo,
R.
Tang
(2015)
A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models
PLoS ONE, 10
-
Crystal
Shanley,
G.
Ireton,
S.
Baldwin,
R.
Coler,
S.
Reed,
R.
Basaraba,
I.
Orme
(2014)
Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.
Tuberculosis, 94 2
-
M.
Merker,
Camille
Blin,
S.
Mona,
N.
Duforet-Frebourg,
Sophie
Lecher,
Eve
Willery,
M.
Blum,
S.
Rüsch-Gerdes,
I.
Mokrousov,
E.
Aleksic,
C.
Allix-Béguec,
A.
Antierens,
E.
AUGUSTYNOWICZ-KOPEĆ,
M.
Ballif,
F.
Barletta,
H.
Beck,
C.
Barry,
M.
Bonnet,
E.
Borroni,
I.
Campos-Herrero,
D.
Cirillo,
H.
Cox,
S.
Crowe,
V.
Crudu,
R.
Diel,
F.
Drobniewski,
M.
Fauville-Dufaux,
S.
Gagneux,
S.
Ghebremichael,
M.
Hanekom,
S.
Hoffner,
W.
Jiao,
S.
Kalon,
T.
Kohl,
I.
Kontsevaya,
Troels
Lillebæk,
S.
Maeda,
V.
Nikolayevskyy,
M.
Rasmussen,
Nalin
Rastogi,
S.
Samper,
E.
Sánchez-Padilla,
B.
Savić,
I.
Shamputa,
A.
Shen,
L.
Sng,
P.
Stakėnas,
K.
Toit,
F.
Varaine,
D.
Vuković,
C.
Wahl,
R.
Warren,
P.
Supply,
S.
Niemann,
T.
Wirth
(2015)
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
Nature Genetics, 47
-
C.
Fox,
S.
Baldwin,
T.
Vedvick,
E.
Angov,
S.
Reed
(2012)
Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines
Clinical and Vaccine Immunology, 19
-
T.
Miyoshi‐Akiyama,
Kazunori
Matsumura,
Hiroki
Iwai,
K.
Funatogawa,
T.
Kirikae
(2012)
Complete Annotated Genome Sequence of Mycobacterium tuberculosis Erdman
Journal of Bacteriology, 194
-
A.
Nalbandian,
Bo-Shiun
Yan,
Bo-Shiun
Yan,
A.
Pichugin,
R.
Bronson,
I.
Kramnik
(2009)
Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control
Oncogene, 28
-
R.
Coler,
S.
Bertholet,
Samuel
Pine,
M.
Orr,
V.
Reese,
H.
Windish,
Charles
Davis,
M.
Kahn,
S.
Baldwin,
S.
Reed
(2013)
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
The Journal of infectious diseases, 207 8
-
I.
Orme
(2014)
Tuberculosis Vaccine Types and Timings
Clinical and Vaccine Immunology, 22
-
L.
Gabbasova,
E.
Who
(2014)
Global tuberculosis report (2014)
-
S.
Baldwin,
N.
Shaverdian,
Y.
Goto,
M.
Duthie,
V.
Raman,
Tara
Evers,
Farah
Mompoint,
T.
Vedvick,
S.
Bertholet,
R.
Coler,
S.
Reed
(2009)
Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
Vaccine, 27 43
-
M.
Sadeghi-shabestari,
N.
Rezaei
(2009)
Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 13 6
-
A.
Pichugin,
Bo-Shiun
Yan,
A.
Sloutsky,
L.
Kobzik,
I.
Kramnik
(2010)
Immunopathology and Infectious Diseases Dominant Role of the sst 1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts
-
M.
Hanekom,
N.
Pittius,
C.
McEvoy,
T.
Victor,
P.
Helden,
R.
Warren
(2011)
Mycobacterium tuberculosis Beijing genotype: a template for success.
Tuberculosis, 91 6
-
T.
Miyoshi‐Akiyama,
K.
Satou,
M.
Kato,
Akino
Shiroma,
Kazunori
Matsumura,
Hinako
Tamotsu,
Hiroki
Iwai,
Kuniko
Teruya,
K.
Funatogawa,
Takashi
Hirano,
T.
Kirikae
(2015)
Complete annotated genome sequence of Mycobacterium tuberculosis (Zopf) Lehmann and Neumann (ATCC35812) (Kurono).
Tuberculosis, 95 1
-
A.
Alangari,
F.
Al-Zamil,
A.
Al-Mazrou,
S.
Al‐Muhsen,
S.
Boisson-Dupuis,
S.
Awadallah,
A.
Kambal,
J.
Casanova
(2010)
Treatment of Disseminated Mycobacterial Infection with High-Dose IFN-γ in a Patient with IL-12Rβ1 Deficiency
Clinical and Developmental Immunology, 2011
-
D.
Ordway,
M.
Henao-Tamayo,
Marisa
Harton,
G.
Palanisamy,
Jolynn
Troudt,
Crystal
Shanley,
R.
Basaraba,
I.
Orme
(2007)
The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1
The Journal of Immunology, 179
-
H.
Chang,
W.
Mitzner,
J.
Watson
(2012)
Variation in airway responsiveness of male C57BL/6 mice from 5 vendors.
Journal of the American Association for Laboratory Animal Science : JAALAS, 51 4
-
Robert
Trimble,
Janet
Atkins,
T.
Quigg,
C.
Burns,
G.
Wallace,
Mary
Thomas,
A.
Mangla,
A.
Infante
(2014)
Vaccine-Associated Paralytic Poliomyelitis and BCG-osis in an Immigrant Child with Severe Combined Immunodeficiency Syndrome — Texas, 2013
Morbidity and Mortality Weekly Report, 63
-
N.
Casali,
V.
Nikolayevskyy,
Y.
Balabanova,
S.
Harris,
O.
Ignatyeva,
I.
Kontsevaya,
J.
Corander,
J.
Bryant,
J.
Parkhill,
S.
Nejentsev,
R.
Horstmann,
T.
Brown,
F.
Drobniewski
(2014)
Evolution and transmission of drug resistant tuberculosis in a Russian population
Nature genetics, 46
-
(2012)
Variation in airway responsiveBaldwin et al. 146 cvi.asm.org February 2016 Volume 23 Number 2 Clinical and Vaccine Immunology ness of male C57BL/6 mice from 5 vendors
-
D.
Ordway,
S.
Shang,
M.
Henao-Tamayo,
A.
Obregón-Henao,
Laura
Nold,
M.
Caraway,
Crystal
Shanley,
R.
Basaraba,
C.
Duncan,
I.
Orme
(2011)
Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells
Clinical and Vaccine Immunology, 18
-
R.
Hunter
(2011)
Pathology of post primary tuberculosis of the lung: an illustrated critical review.
Tuberculosis, 91 6
-
C.
Clegg,
R.
Roque,
N.
Hoeven,
Lucy
Perrone,
S.
Baldwin,
J.
Rininger,
R.
Bowen,
S.
Reed
(2012)
Adjuvant solution for pandemic influenza vaccine production
Proceedings of the National Academy of Sciences, 109
-
M.
Duthie,
L.
Sampaio,
R.
Oliveira,
V.
Raman,
Joanne
O’Donnell,
H.
Bailor,
G.
Ireton,
A.
Sousa,
M.
Stefani,
S.
Reed
(2013)
Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.
Vaccine, 31 5
-
R.
Coler,
S.
Bertholet,
Magdalini
Moutaftsi,
J.
Guderian,
H.
Windish,
S.
Baldwin,
Elsa
Laughlin,
M.
Duthie,
C.
Fox,
D.
Carter,
M.
Friede,
T.
Vedvick,
S.
Reed
(2011)
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
PLoS ONE, 6
-
S.
Bertholet,
Y.
Goto,
L.
Carter,
A.
Bhatia,
R.
Howard,
D.
Carter,
R.
Coler,
T.
Vedvick,
S.
Reed
(2009)
Optimized subunit vaccine protects against experimental leishmaniasis.
Vaccine, 27 50
-
U.
Fruth,
D.
Young
(2004)
Prospects for new TB vaccines: Stop TB Working Group on TB Vaccine Development.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 8 1
-
S.
Bertholet,
G.
Ireton,
D.
Ordway,
H.
Windish,
Samuel
Pine,
M.
Kahn,
Tony
Phan,
I.
Orme,
T.
Vedvick,
S.
Baldwin,
R.
Coler,
S.
Reed
(2010)
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
Science Translational Medicine, 2
-
B.
Guy
(2007)
The perfect mix: recent progress in adjuvant research
Nature Reviews Microbiology, 5
-
Bo-Young
Jeon,
S.
Derrick,
Jae-Hyun
Lim,
Kristopher
Kolibab,
V.
Dheenadhayalan,
A.
Yang,
B.
Kreiswirth,
S.
Morris
(2008)
Mycobacterium bovis BCG Immunization Induces Protective Immunity against Nine Different Mycobacterium tuberculosis Strains in Mice
Infection and Immunity, 76
-
Medina,
North
(1998)
Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype
Immunology, 93
-
S.
Reed,
S.
Bertholet,
R.
Coler,
M.
Friede
(2009)
New horizons in adjuvants for vaccine development.
Trends in immunology, 30 1
-
M.
Orr,
H.
Windish,
Elyse
Beebe,
David
Argilla,
Po-wei
Huang,
V.
Reese,
S.
Reed,
R.
Coler
(2015)
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.
The Journal of infectious diseases, 212 3
-
J.
Bayry,
E.
Tartour,
D.
Tough
(2014)
Targeting CCR4 as an emerging strategy for cancer therapy and vaccines.
Trends in pharmacological sciences, 35 4
-
Matthew
Falagas,
V.
Kouranos,
Z.
Athanassa,
P.
Kopterides
(2010)
Tuberculosis and malignancy.
QJM : monthly journal of the Association of Physicians, 103 7
-
W.
Steenken,
L.
Gardner
(1946)
History of H37 strain of tubercle bacillus.
American review of tuberculosis, 54
-
W.
Hillebrand
(1866)
On Leprosy
The Indian Medical Gazette, 1
-
Swati
Singh,
Iti
Saraav,
Sadhna
Sharma
(2014)
Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Vaccine, 32 6
-
C.
Manca,
L.
Tsenova,
A.
Bergtold,
S.
Freeman,
Micah
Tovey,
J.
Musser,
C.
Barry,
V.
Freedman,
G.
Kaplan
(2001)
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
Proceedings of the National Academy of Sciences of the United States of America, 98
-
S.
Bertholet,
G.
Ireton,
M.
Kahn,
J.
Guderian,
R.
Mohamath,
Nicole
Stride,
Elsa
Laughlin,
S.
Baldwin,
T.
Vedvick,
R.
Coler,
S.
Reed
(2008)
This information is current as Mycobacterium tuberculosis the Development of Vaccines against Identification of Human T Cell Antigens for Coler
-
J.
Pease,
R.
Horuk
(2014)
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
Expert Opinion on Drug Discovery, 9
-
G.
Palanisamy,
N.
Duteau,
K.
Eisenach,
D.
Cave,
S.
Theus,
B.
Kreiswirth,
R.
Basaraba,
I.
Orme
(2009)
Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs.
Tuberculosis, 89 3
-
Souvik
Karmakar,
Weidong
Zhang,
G.
Ahmad,
W.
Torben,
M.
Alam,
Loc
Le,
R.
Damian,
R.
Wolf,
G.
White,
D.
Carey,
D.
Carter,
S.
Reed,
A.
Siddiqui
(2014)
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
Vaccine, 32 11
-
H.
McShane,
Ann
Williams
(2014)
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data☆
Tuberculosis (Edinburgh, Scotland), 94
-
A.
Aplogan,
V.
Mangindula,
G.
Mwema,
L.
Okito,
Herpesvirus
Br
(2015)
From the Centers for Disease Control and Prevention
-
M.
Ho,
J.
Southern,
Hye-Na
Kang,
I.
Knezevic
(2010)
WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22-23 September 2009.
Vaccine, 28 43
-
(2008)
BMC Microbiology BioMed Central
-
I.
Orme,
R.
Robinson,
A.
Cooper
(2014)
The balance between protective and pathogenic immune responses in the TB-infected lung
Nature Immunology, 16
-
T.
Ottenhoff,
Ranjeeta
Dass,
N.
Yang,
Mingzi
Zhang,
H.
Wong,
E.
Sahiratmadja,
C.
Khor,
B.
Alisjahbana,
R.
Crevel,
S.
Marzuki,
Mark
Seielstad,
E.
Vosse,
M.
Hibberd
(2012)
Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active Tuberculosis
PLoS ONE, 7
-
M.
Berry,
C.
Graham,
Finlay
Mcnab,
Zhaohui
Xu,
S.
Bloch,
T.
Oni,
K.
Wilkinson,
R.
Banchereau,
Jason
Skinner,
R.
Wilkinson,
Charlie
Quinn,
D.
Blankenship,
R.
Dhawan,
J.
Cush,
A.
Mejías,
O.
Ramilo,
O.
Kon,
V.
Pascual,
J.
Banchereau,
D.
Chaussabel,
A.
O’Garra
(2010)
An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis
Nature, 466
-
R.
Fernandes,
E.
Medina-Acosta
(2010)
BCG-itis in two antiretroviral-treated HIV-infected infants
International Journal of STD & AIDS, 21
-
C.
Manca,
Michael
Reed,
S.
Freeman,
B.
Mathema,
B.
Kreiswirth,
C.
Barry,
G.
Kaplan
(2004)
Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis
Infection and Immunity, 72
-
Rabia
Johnson,
Robin
Warren,
O.
Strauss,
Jordaan
Am,
A.
Falmer,
N.
Beyers,
H.
Schaaf,
Megan
Murray,
Karen
Cloete,
P.
Helden,
T.
Victor
(2006)
An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 10 12
-
P.
Bifani,
B.
Mathema,
Zhiyuan
Liu,
S.
Moghazeh,
B.
Shopsin,
B.
Tempalski,
Jeffrey
Driscoll,
R.
Frothingham,
J.
Musser,
P.
Alcabes,
B.
Kreiswirth
(1999)
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
JAMA, 282 24